#Latest news with #H.U.GroupHoldingsAU Financial Review17-05-2025HealthAU Financial Review‘Game changer' Alzheimer's blood test cleared in the USUS regulators have approved the first blood test to help diagnose Alzheimer's disease, potentially making it easier to find and treat patients with the mind-robbing disease that affects nearly 7 million Americans. The test made by Fujirebio Diagnostics a unit of Japan's H.U. Group Holdings was cleared for people 55 years and older who exhibit signs and symptoms of the disease, the US Food and Drug Administration said in a statement.
AU Financial Review17-05-2025HealthAU Financial Review‘Game changer' Alzheimer's blood test cleared in the USUS regulators have approved the first blood test to help diagnose Alzheimer's disease, potentially making it easier to find and treat patients with the mind-robbing disease that affects nearly 7 million Americans. The test made by Fujirebio Diagnostics a unit of Japan's H.U. Group Holdings was cleared for people 55 years and older who exhibit signs and symptoms of the disease, the US Food and Drug Administration said in a statement.
17-05-2025
